NCT03048006View on ClinicalTrials.gov

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

CompletedOBSERVATIONAL
Enrollment

44,456

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Contrast-enhanced MRI With Dotarem
Interventions
PROCEDURE

MRI with Dotarem

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY